ASRT vs MS · rev $125.0M vs P/E 20, $344.27B cap
Assertio Therapeutics Inc (ASRT) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
MS does not have a complete income-statement cache yet.
ASRT currently screens at market cap $151.5M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the ASRT and MS stock pages for the full models.
Not investment advice.